• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基因疗法在亚致死剂量照射的受体中诱导供体特异性耐受。

Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.

作者信息

Forman Daron, Tian Chaorui, Iacomini John

机构信息

Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Mol Ther. 2005 Aug;12(2):353-9. doi: 10.1016/j.ymthe.2005.03.035.

DOI:10.1016/j.ymthe.2005.03.035
PMID:15939670
Abstract

Donor-specific transplantation tolerance can be established through the induction of molecular chimerism following reconstitution of lethally irradiated mice with autologous bone marrow expressing retrovirally transduced allogeneic MHC antigens. Here, we set out to define nonmyeloablative host conditioning regimens that would allow for establishment of molecular chimerism and the induction of donor-specific tolerance. Recipient mice received various doses of whole-body irradiation, together with costimulatory blockade using anti-CD154 monoclonal antibody prior to reconstitution with syngeneic bone marrow cells transduced with retroviruses carrying the gene encoding H-2K(b). Conditioning consisting of 3 Gy whole-body irradiation and treatment with anti-CD154 was sufficient to induce molecular chimerism resulting in stable multilineage expression of K(b) on hematopoietic cells. T cells from molecular chimeras were unable to lyse allogeneic targets expressing K(b) and contained substantially fewer K(b)-reactive IL-2- and IFN-gamma-producing CD4 T cells than controls receiving mock-transduced bone marrow. Induction of molecular chimerism using nonmyeloablative host conditioning allowed for permanent survival of K(b)-disparate allogeneic skin grafts. These data suggest that nonmyeloablative host conditioning can be used effectively to induce molecular chimerism resulting in transplantation tolerance.

摘要

通过用表达逆转录病毒转导的同种异体MHC抗原的自体骨髓重建经致死性照射的小鼠,诱导分子嵌合,可建立供体特异性移植耐受。在此,我们着手确定非清髓性宿主预处理方案,该方案将允许建立分子嵌合并诱导供体特异性耐受。在接受携带编码H-2K(b)基因的逆转录病毒转导的同基因骨髓细胞重建之前,受体小鼠接受不同剂量的全身照射,并使用抗CD154单克隆抗体进行共刺激阻断。由3 Gy全身照射和抗CD154治疗组成的预处理足以诱导分子嵌合,导致造血细胞上K(b)的稳定多谱系表达。分子嵌合体的T细胞不能裂解表达K(b)的同种异体靶细胞,并且与接受模拟转导骨髓的对照相比,产生K(b)反应性IL-2和IFN-γ的CD4 T细胞明显减少。使用非清髓性宿主预处理诱导分子嵌合可使K(b)不相合的同种异体皮肤移植物永久存活。这些数据表明,非清髓性宿主预处理可有效地用于诱导分子嵌合,从而导致移植耐受。

相似文献

1
Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.通过基因疗法在亚致死剂量照射的受体中诱导供体特异性耐受。
Mol Ther. 2005 Aug;12(2):353-9. doi: 10.1016/j.ymthe.2005.03.035.
2
Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.使用去除T细胞的抗体、环磷酰胺和胸腺照射进行非清髓性预处理后诱导稳定的长期混合造血嵌合状态,可导致供体特异性的体外和体内耐受。
Biol Blood Marrow Transplant. 2001;7(12):646-55. doi: 10.1053/bbmt.2001.v7.pm11787527.
3
A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.一种非致死性预处理方法,用于跨越主要、次要和造血组织相容性屏障实现持久的多谱系混合嵌合和耐受。
J Immunol. 1995 Nov 1;155(9):4179-88.
4
Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.凋亡的供体白细胞限制了同种异体骨髓移植中CD40 - CD154阻断诱导的混合嵌合现象。
Biol Blood Marrow Transplant. 2006 Dec;12(12):1239-49. doi: 10.1016/j.bbmt.2006.08.038.
5
Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.在非清髓性且无辐照预处理治疗下,阻断CD40/CD154通路可增强去除T细胞的异基因骨髓植入。
Transplantation. 2003 Jul 15;76(1):216-24. doi: 10.1097/01.TP.0000069602.30162.A1.
6
Tolerance induction through megadose bone marrow transplantation with two-signal blockade.通过大剂量骨髓移植和双信号阻断诱导耐受。
J Surg Res. 2006 Jan;130(1):102-9. doi: 10.1016/j.jss.2005.07.042. Epub 2005 Sep 23.
7
Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.抗自然杀伤细胞治疗在主要组织相容性复合体不匹配、T细胞去除、非清髓性骨髓移植中诱导稳定的混合嵌合状态。
Exp Hematol. 2004 Dec;32(12):1246-54. doi: 10.1016/j.exphem.2004.08.008.
8
Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.通过基于非致死性辐射的细胞减灭方法实现持久的混合异体嵌合和耐受。
J Immunol. 1996 Oct 1;157(7):2820-9.
9
Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.抗小鼠CD154抗体治疗有助于在小鼠中产生混合异种大鼠造血嵌合体,预防消瘦病并延长异种移植物的存活时间。
Xenotransplantation. 2006 May;13(3):224-32. doi: 10.1111/j.1399-3089.2006.00290.x.
10
Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.共刺激信号CD28 - CD80和CD40 - CD154的同时阻断,联合抗CD25单克隆抗体,可在大鼠中诱导稳定的嵌合状态和耐受性,且无移植物抗宿主病。
Eur Surg Res. 2011;46(3):109-17. doi: 10.1159/000323011. Epub 2011 Jan 15.

引用本文的文献

1
Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects.非病毒和病毒传递系统治疗 A 型血友病:最新进展与展望。
Ann Hematol. 2024 May;103(5):1493-1511. doi: 10.1007/s00277-023-05459-0. Epub 2023 Nov 11.
2
Engraftment of retrovirally transduced Bet v 1-GFP expressing bone marrow cells leads to allergen-specific tolerance.逆转录病毒转导的 Bet v 1-GFP 表达骨髓细胞的植入导致过敏原特异性耐受。
Immunobiology. 2013 Sep;218(9):1139-46. doi: 10.1016/j.imbio.2013.03.007. Epub 2013 Mar 30.
3
Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.
通过骨髓的基因修饰实现对 MHC Ⅱ类不同异体移植物的耐受
Gene Ther. 2013 May;20(5):478-86. doi: 10.1038/gt.2012.57. Epub 2012 Jul 26.
4
Thymic gene transfer of myelin oligodendrocyte glycoprotein ameliorates the onset but not the progression of autoimmune demyelination.胸腺基因转移髓鞘少突胶质糖蛋白可改善自身免疫性脱髓鞘的发病但不能改善其进展。
Mol Ther. 2012 Jul;20(7):1349-59. doi: 10.1038/mt.2012.15. Epub 2012 Feb 21.
5
Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.通过 T 细胞介导的同种异体抗原传递诱导完全错配心脏移植物的移植耐受。
Clin Immunol. 2010 Aug;136(2):174-87. doi: 10.1016/j.clim.2010.04.012. Epub 2010 May 8.
6
Human gene therapy and imaging in neurological diseases.人类基因治疗与神经疾病成像
Eur J Nucl Med Mol Imaging. 2005 Dec;32 Suppl 2(Suppl 2):S358-83. doi: 10.1007/s00259-005-1960-3.
7
Correction of murine hemophilia A by hematopoietic stem cell gene therapy.通过造血干细胞基因疗法纠正小鼠血友病A。
Mol Ther. 2005 Dec;12(6):1034-42. doi: 10.1016/j.ymthe.2005.09.007. Epub 2005 Oct 12.